Perazella Mark A, Herlitz Leal C
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Section of Nephrology, Department of Medicine, VA Medical Center, West Haven, Connecticut, USA.
Kidney Int Rep. 2021 Sep 17;6(12):2942-2957. doi: 10.1016/j.ekir.2021.09.003. eCollection 2021 Dec.
Crystalline nephropathies are a unique form of kidney disease characterized by the histologic finding of intrarenal crystal deposition. The intrinsic nature of some molecules and ions combined with a favorable tubular fluid physiology leads to crystal precipitation and deposition within the tubular lumens. Crystal deposition promotes kidney injury through tubular obstruction and both direct and indirect cytotoxicities. Further kidney injury develops from inflammation triggered by these crystals. From a clinical standpoint, the crystalline nephropathies are associated with abnormal urinalysis and urinary sediment findings, tubulopathies, acute kidney injury (AKI), and/or chronic kidney disease (CKD). Urine sediment examination is often helpful in alerting clinicians to the possibility of crystal-related kidney injury. The identification of crystals within the kidneys on biopsy by pathologists prompts clinicians to evaluate patients for medication-related kidney injury, dysproteinemia-related malignancies, and certain inherited disorders. This review will focus on the clinical and pathologic aspects of these 3 categories of crystalline nephropathies.
结晶性肾病是一种独特的肾脏疾病形式,其特征是在组织学上发现肾内晶体沉积。某些分子和离子的内在性质,加上有利的肾小管液生理状况,导致晶体在肾小管腔内沉淀和沉积。晶体沉积通过肾小管阻塞以及直接和间接细胞毒性促进肾损伤。这些晶体引发的炎症会进一步导致肾脏损伤。从临床角度来看,结晶性肾病与尿液分析异常、尿沉渣检查结果、肾小管疾病、急性肾损伤(AKI)和/或慢性肾脏病(CKD)相关。尿沉渣检查通常有助于提醒临床医生注意晶体相关肾损伤的可能性。病理学家在活检时在肾脏中发现晶体,促使临床医生对患者进行与药物相关的肾损伤、与异常蛋白血症相关的恶性肿瘤以及某些遗传性疾病的评估。本综述将重点关注这三类结晶性肾病的临床和病理方面。